In vitro RNA synthesis by tobacco mosaic virus and cowpea chlorotic mottle virus replicase were inhibited by cordycepin triphosphate. Inhibition could be overcome with higher concentrations of ATP in assay mixtures but not with UTP. Products synthesized in vitro by tobacco mosaic virus RNA replicase in the presence of inhibitor revealed replicative form but not replicative intermediate RNAs. These results suggest that cordycepin triphosphate competes specifically with ATP and results in premature termination of viral RNA synthesis in vitro.
In vitro RNA synthesis by tobacco mosaic virus and cowpea chlorotic mottle virus replicase were inhibited by cordycepin triphosphate. Inhibition could be overcome with higher concentrations of ATP in assay mixtures but not with UTP. Products synthesized in vitro by tobacco mosaic virus RNA replicase in the presence of inhibitor revealed replicative form but not replicative intermediate RNAs. These results suggest that cordycepin triphosphate competes specifically with ATP and results in premature termination of viral RNA synthesis in vitro.
Cordycepin (3'-deoxyadenosine), the first nucleoside antibiotic, inhibits synthesis of specific cellular (2) and viral (7, 8, 13) RNAs, while synthesis of other RNAs is unaffected (2, 4, 6, 8, 10) . This antibiotic's inhibitory effects are probably due to its conversion in vitro to the nucleoside triphosphate that inhibits RNA polymerases (5) . The inhibition is caused by premature termination ofRNA synthesis, but incorporation of 3'-deoxyadenosine monophosphate (3'-dAMP) in place of AMP has not been established. However, AMP, not 3'-dAMP, has been found to be the terminal nucleoside in RNA chains prematurely terminated by cordycepin in vivo (2) . Using picornavirus polymerase complexes, Panicalli and Nair (9) demonstrated that the presence of cordycepin triphosphate (3'-dATP) inhibited RNA synthesis in vitro and that the inhibitor promptly and specifically competes with ATP, preventing in vitro incorporation of AMP residues into virus-specified singlestranded RNA.
Although numerous inhibitors have been reported to block replication of plant viruses (12) , the molecular basis of inhibition is uncertain. In synchronously infected tobacco mosaic virus (TMV)-infected tobacco leaves or cowpea chlorotic mottle virus (CCMV)-infected cowpea leaves (3), viral replication becomes sensitive to cordycepin beginning at 12 h after infection and continuing to 48 h (unpublished data). The time course of cordycepin inhibition paralleled that of virus-specified RNA and replicase synthesis. To further investigate the site and mechanism of action of cordycepin, we studied the effect of 3'-dATP on inhibition of in vitro RNA synthesis by two different plant virus replicases with different properties, those from TMV and CCMV. Our results suggest that 3'-dATP specifically competes with ATP and prevents in vitro incorporation of AMP into replicative form and intertnediate RNAs.
3'-dATP and other biochemicals were obtained from Sigma Chemical Co.; [3H]ATP (49 Ci/mmol) and [3H]UTP (32 Ci/mmol) were obtained from ICN Pharmaceuticals. Primary leaves of cowpea Vigna unguiculata (L.) walp. California Blackeye were inoculated with crude sap from plants infected with CCMV and harvested 4 days later for extraction. CCMV-infected cowpea leaves were homogenized in 0.05 M Tris-hydrochloride (pH 7.4 at 4°C), 0.01 M KCl, 0.001 M EDTA, and 2.5 mM dithiothreitol (5 ml/g of tissue) in a chilled mortar. The homogenate was filtered through two layers of Miracloth, and the filtrate was centrifuged at 1,000 x g for 10 min. The supernatant fraction was adjusted to 20% glycerol and centrifuged at 31,000 x g for 30 min. The pellet was suspended in 0.05 M Tris-hydrochloride (pH 8.0 at 4°C), 0.5 M KCl, 0.01 M MgCl2, 0.001 M EDTA, 5% glycerol, and 2.5 mM dithiothreitol (0.1 ml/g of tissue) with the aid of a tissue homogenizer and sedimented at 31,000 x g for 30 min. The pellet was suspended in fresh buffer and centrifuged again. Th,e final 31,000 x g pellet was suspended in 10 mM Tris-hydrochloride (pH 8.0 at 35°C), 10 mM KCl, 25 mM (NH4)2SO4, 5% glycerol, and 2.5 mM dithiothreitol (0.1 ml/g of tissue) and used as the source of bound CCMV replicase (15) . A similar procedure was used for the preparation of TMV replicase, except different buffers were used (14) . The standard RNA assay mixture contained 100 mM Tris-hydrochloride (pH 8.0 at 35°C), 10 mM MgCl2, 7.5 mM dithiothreitol, 25 mM (NH4)2SO4, 10 jig of actinomycin D per ml, 0.1 ,umol each of CTP and GTP per ml, 1 to 2 nmol of [3H]UTP per ml, and varying concentrations of ATP (0.1 to 1.0 pmol/ml). The reaction was initiated by adding the enzyme and was terminated by transferring two 40-pl samples onto a 2.3-cm disk of Whatman 3MM filter paper, which was then placed into cold 5% trichloroacetic acid containing 1% sodium pyrophosphate and 0.02% uracil. The disks were further processed, and radioactivity was determined as previously described (16) . Each data point represents the average of duplicate samples minus the average of the zero time values. RNA was isolated from scaled-up reaction mixtures and analyzed on polyacrylamide gels (15) .
The 31,000 x g membrane fractions were prepared from plants infected with TMV or CCMV and from uninfected plants. (Fig.  2) . The Lineweaver-Burk plot of [3H]UMP polymerization in the presence of excess ATP (Fig.  2, insert) suggests competitive inhibition. The inhibition was not overcome when increasing concentrations of UTP were added to the initial assay mixtures. Addition of excess ATP 15 min after the inhibitor did not reverse inhibition (not shown). Similar results were obtained for CCMV replicase (not shown).
The products of in vitro RNA synthesis by TMV replicase are replicative form (Fig. 3 , gel slice no. 7 to 9) and replicative intermediate ( (Fig. 3) . Replicative intermediate RNA was detected in low amounts in RNA isolated from reaction mixtures containing the inhibitor. However, additional double-stranded RNAs smaller than the replicative form (Fig. 3, gel slice no. 11 to 15) were detected in products isolated from reaction mixtures containing 3'-dATP. The origin of these virus-specific RNAs is unclear.
3'-dATP inhibited TMV and CCMV replicases in vitro. The inhibition could be overcome by increasing ATP but not UTP concentrations in assay mixtures. It appears that the incorporation of AMP into growing viral RNA chains is specifically blocked by 3'-dATP. Other evidence supports this hypothesis: in vitro RNA synthesis in the presence of 3'-dATP by poliovirus and rhinovirus polymerase complexes was specifically inhibited (9) , and 3'-dATP inhibits transcription of polyadenylic acid from a polyuridylic acid template by procaryotic DNA-dependent RNA polymerase (11). 3'-dATP reduced the in vitro synthesis of TMV replicative intermediate RNA to a greater extent than the replicative form (Fig. 3) . These results are consistent with the proposal that cordycepin's mode of action is by termination of RNA chain elongation. From these results and others (5, 9), it is not possible to determine whether or not 3'-dAMP is incorporated into RNA. The failure to reverse inhi- bition by addition of excess ATP 15 min after addition of the inhibitor is consistent with irreversible binding of the inhibitor to viral replicase or incorporation of 3'-dAMP into RNA. In vivo data suggest that 3'-dAMP is not incorporated into RNA chains (2) .
The plant viral replicase sensitivity to 3'-dATP is similar to the inhibitor's action upon DNA-dependent RNA polymerase II1(5), poliovirus polymerase, and rhinovirus polymerase (9) . This sensitivity to 3'-dATP may indicate similarities in site(s) in the polymerase ATP-utilizing enzymes where ATP and 3'-dATP act.
When ATP was the sole nucleotide precursor present, the incorporation obtained with viral replicases was comparable to that obtained with control cell preparations. Both activities were inhibited by 3'-dATP. There appears to be no virus-specific polyadenylic acid polymerase activity.
